Time (CEST) Option 1 / 2
Wednesday, 27 October 2021 SESSION 1: PROPHYLAXIS AND
CURRENT CLINICAL PRACTICE
Time (CEST) Option 1 / 2
Thursday, 28 October 2021SESSION 2: REVISITING SAFETY OF
CURRENT HAEMOPHILIA CARE
Time (CEST) Option 1 / 2
Friday 29 October 2021 SESSION 3: HAEMOPHILIA CARE:
LOOKING TO THE FUTURE
09:00 / 16:00
Welcome to the 12th Haemophilia
Global Summit
09:00 / 16:00
Welcome to Day 2 of the
12th Haemophilia Global Summit
09:00 / 16:00
Welcome to Day 3 of the
12th Haemophilia Global Summit
09:10 /16:10
KEYNOTE ADDRESS: Excellence in care:
Prophylaxis – expectations of care in 2021
09:05 / 16:05
KEYNOTE ADDRESS: Safety aspects of modern haemophilia care: looking beyond pathogen safety
09:05 / 16:05
KEYNOTE ADDRESS: Haemophilia in tomorrow’s world: 2022 and beyond
09:30 /16:30
SLAM: Current classifications of
haemophilia severity: are they still fit for purpose?
09:25 /16:25
SLAM: Does hepatitis C infection belong in the past?
09:25 /16:25
MASTERCLASS: Assessment of novel haemophilia therapies: new challenges for the haemostasis laboratories
09:40 / 16:40
MASTERCLASS: Activity and lifestyle: key aspects of individualisation of haemophilia therapy
09:35 / 16:35
SLAM: COVID-19 and haemophilia: practical implications and lessons for the future
09:40 / 16:40
SLAM: The position of future therapies in resource-constrained countries: global perspectives
09:55 / 16:55
MASTERCLASS: Navigating the transition from paediatric to adult care
09:45 / 16:45
SLAM: Future risk profiling for comorbidities in the older patient
09:50 / 16:50
SLAM: Delivering quality care from afar: managing geographical challenges of haemophilia care
10:10 / 17:10
SLAM: Women with haemophilia: how has care evolved?
09:55 / 16:55
SLAM: The role of immune tolerance in an era of evolving therapeutic options
10:00 / 17:00
MASTERCLASS: Evolving comprehensive care in an era of novel therapies
10:20 / 17:20
Live Q&A session
10:05/17:05
SLAM: Can haemophilia B inhibitors be tolerised?
10:15/17:15
SLAM: Unfolding considerations: a focus on the unknowns of gene therapy
10:40 / 17:40
Summary and close
10:15 / 17:15
Live Q&A session
10:25 / 17:25
Live Q&A session
10:35 / 17:35
Summary and close
10:45 / 17:45
Steering Committee Close